Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer
Author:
Funder
Sanofi
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Oral Surgery
Reference22 articles.
1. Globocan, 2012 - Home n.d. http://globocan.iarc.fr/Default.aspx [accessed August 19, 2015].
2. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium;Hashibe;Cancer Epidemiol Biomarkers Prev,2009
3. Head and neck cancer;Argiris;Lancet,2008
4. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial;Ghosh-Laskar;Head Neck,2016
5. Guidelines for treatment of recurrent or metastatic head and neck cancer;Parikh;Indian J Cancer,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma;Biomedicines;2023-10-25
2. Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer;Oral Oncology;2022-11
3. Comparison of Second-Line Treatments for Patients with Platinum-Resistant Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis;Cancers;2022-09-15
4. Clinical trial outcomes in oral squamous cell carcinoma: A pragmatic ideation;Oral Oncology;2022-03
5. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy;Cochrane Database of Systematic Reviews;2021-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3